6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 24 Jul 2026
- Reporting date
- 24 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,801 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 1-25 of 1,000 matching filings.
Per page
25
Current page
1
6-K
File 001-15170
ADMISSION TO TRADING
- Filing date
- 24 Jul 2026
- Reporting date
- 24 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
JIDEYTRO APPROVED IN US FOR CERTAIN LUNG CANCERS
- Filing date
- 22 Jul 2026
- Reporting date
- 22 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BEXSERO 1-DOSE BOOSTER EMA FILE ACCEPTANCE
- Filing date
- 20 Jul 2026
- Reporting date
- 20 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
AUDIT TENDER CONCLUSION
- Filing date
- 17 Jul 2026
- Reporting date
- 17 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
CAMLIPIXANT PHASE III RESULTS UPDATE
- Filing date
- 17 Jul 2026
- Reporting date
- 17 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 16 Jul 2026
- Reporting date
- 16 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK COMPLETES ACQUISITION OF NUVALENT, INC
- Filing date
- 15 Jul 2026
- Reporting date
- 15 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC TO-T/A
SC TO-T/A
- Filing date
- 15 Jul 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 14 Jul 2026
- Reporting date
- 14 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 13 Jul 2026
- Reporting date
- 13 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
POSITIVE JEMPERLI DATA IN DMMR/MSI-H RECTAL CANCER
- Filing date
- 13 Jul 2026
- Reporting date
- 13 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC TO-T/A
SC TO-T/A
- Filing date
- 10 Jul 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
HANSOH POSITIVE PHASE III RESULTS FOR RIZ-REZ
- Filing date
- 10 Jul 2026
- Reporting date
- 10 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 09 Jul 2026
- Reporting date
- 09 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTORATE CHANGE
- Filing date
- 09 Jul 2026
- Reporting date
- 09 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC TO-T/A
SC TO-T/A
- Filing date
- 07 Jul 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Jul 2026
- Reporting date
- 01 Jul 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 29 Jun 2026
- Reporting date
- 29 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
HOLDING(S) IN COMPANY
- Filing date
- 29 Jun 2026
- Reporting date
- 29 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
HOLDING(S) IN COMPANY
- Filing date
- 26 Jun 2026
- Reporting date
- 26 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC TO-T/A
SC TO-T/A
- Filing date
- 24 Jun 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 24 Jun 2026
- Reporting date
- 24 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK ANNOUNCES TENDER OFFER TO ACQUIRE NUVALENT
- Filing date
- 24 Jun 2026
- Reporting date
- 24 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC TO-T
SC TO-T
- Filing date
- 24 Jun 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing